RESITUNE Canadian Trademark Information
Pharmaceutical preparations for the treatment of: psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease; growth and thyroid disorders; seizures; neuromuscular diseases and disorder, namely, brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases; degenerative nerve diseases; multiple sclerosis; cranial and facial nerve disorders; tissue injuries, and bone and cartilage injuries, diseases and disorders; pelvic, urological and reproductive system diseases and disorders, namely infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the relief of allergies, hypertension, menopause and pain; antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectectible contraceptives, human vaccines and smoking cessation medications.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment psychiatric diseases brain disorders mood anxiety cognitive disorders alzheimers cerebral palsy parkinsons disease huntingtons disease growth thyroid disorders seizures neuromuscular diseases disorder brain central
Abandonment Notice!
On Wednesday, November 4, 2015,
status on the RESITUNE
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Thursday, October 11, 2012, a canadian trademark registration was filed for
RESITUNE by Pfizer Inc. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1597755.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
RESITUNE is
TORYS LLP of *********, **********, ***** ****
The RESITUNE
trademark is filed in the description of
Pharmaceutical preparations for the treatment of: psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease; growth and thyroid disorders; seizures; neuromuscular diseases and disorder, namely, brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases; degenerative nerve diseases; multiple sclerosis; cranial and facial nerve disorders; tissue injuries, and bone and cartilage injuries, diseases and disorders; pelvic, urological and reproductive system diseases and disorders, namely infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the relief of allergies, hypertension, menopause and pain; antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectectible contraceptives, human vaccines and smoking cessation medications.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information